Molecular Study on Physiological and Clinical Significance of Adrenomedullin

肾上腺髓质素生理和临床意义的分子研究

基本信息

  • 批准号:
    10218204
  • 负责人:
  • 金额:
    $ 39.81万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
  • 财政年份:
    1998
  • 资助国家:
    日本
  • 起止时间:
    1998 至 2002
  • 项目状态:
    已结题

项目摘要

Adrenomedullin (AM), a potent vasorelaxing and natriuretic peptide, is thought to act as an autocrine/paracrine regulator in the vasculature as well as in renal glomeruli and tubules.In cultured bovine aortic endothelial cells, we have shown that both shear stress and oxidative stress markedly augment the synthesis and secretion of AM. Using specific anti-AM monoclonal antibody we prepared, we have demonstrated that endogenous AM produced by the endothelium inhibits PDGF-induced cell proliferation and strongly downregulates the endothelin secretion in an autocrine manner, thereby potentially protecting against vascular insults. On the other hand, AM potently stimulated the proliferation and migration of quiescent human umbilical vein endothelial cells. Using gel plug assay and laser Doppler imaging, AM stimulated vascular formation in vivo as well. We have shown that these effects of AM are mediated via the cAMP/PKA/PI3K pathway. Furthermore, we have already succeeded in the identifica … More tion and establishment of vascular progenitor cells from mouse ES cells. Using this in vitro vasculogenesis model, we found that AM receptor components, RAMP2 and CRLR, are expressed from an early stages of vascular development, suggesting that AM may play a role in vasculogenesis in vivo.In the kidney, We have shown that a significant amount of AM is produced from mesangial cells. We have demonstrated that RAMP2 and CRLR are markedly upregulated during the progression of renal fibrosis using an obstructive nephropathy model. We also showed that injured renal tissues exhibited enhanced basal and AM-stimulated cAMP production, and addition of AM in cultured renal fibroblasts inhibited proliferation and TGF-β-stimulated extracellular matrix production in a cAMP-dependent fashion.These results suggest that AM potentially exerts protective effects in the vasculature, by enhancing endothelial repair and regeneration as well as probably angiogenesis, and in the kidney, by counteracting the fibrogenic stimuli such as TGF-β. In addition, the activation of AM and its receptor system during vascular and renal injury, if any, should play a role in modulating the process of vascular and renal remodeling, against the disease progression. Less
肾上腺肾上腺素(AM)是一种有效的血管肌和纳地尿肽,是在肾小管和肾小管中的自分泌/旁分泌调节剂。 AM的分泌。内皮产生的AM抑制了PDGF诱导的细胞增殖,并强烈下调了内皮素的分泌物,可能会防止血管损伤。 LS。使用凝胶插头和lasser多普勒成像,我们在体内也表明了AM的这些效果。来自小鼠ES细胞的Genitor细胞。 VE表明,在Mesange细胞中产生了大量AM。 。

项目成果

期刊论文数量(124)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Tetsuya Nagae: "Rat receptor-activity-modifying proteins (RAMPs) for adrenomedullin/CGRP receptor : Cloning and upregulation in obstructive nephropathy"Biochemical and Biophysical Research Communications. (発売予定). (2000)
Tetsuya Nagae:“肾上腺髓质素/CGRP 受体的大鼠受体活性修饰蛋白(RAMP):阻塞性肾病的克隆和上调”《生物化学和生物物理研究通讯》(待发布)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
H.Makino: "Prevention of diabetic nephropathy in rats by prostaglandin E receptor EP_1-selective antagonist"Journal of the American Society of Nephrology. 13(7). 1757-1765 (2002)
H.Makino:“前列腺素E受体EP_1选择性拮抗剂预防大鼠糖尿病肾病”美国肾脏病学会杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Tokuji Tanaka: "Down-regulation of peroxisome proliferator-activated receptor γ expression by inflammatory cytokines and its reversal by thiazolidinediones"Diabetologia. 42(6). 702-710 (1999)
Tokuji Tanaka:“炎症细胞因子对过氧化物酶体增殖物激活受体 γ 表达的下调及其由噻唑烷二酮类的逆转”,Diabetologia 42(6) (1999)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Koichiro Kuwahara: "Involvement of cardiotrophin ?1 in cardiac myocyte-nonmyocyte interactions during hypertrophy of rat cardiac myocytes in vitro"Circulation. 100(15). 1116-1124 (1999)
Koichiro Kuwahara:“心肌营养素α1参与体外大鼠心肌细胞肥大过程中心肌细胞-非肌细胞相互作用”循环。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Takatoshi Saito: "Coordinate regulation of endothelin and adrenomedullin secretion by oxidative stress in endothelial cells"American Journal of Physiology. 281(3). H1364-H1371 (2001)
Takatoshi Saito:“内皮细胞氧化应激对内皮素和肾上腺髓质素分泌的协调调节”美国生理学杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NAKAO Kazuwa其他文献

NAKAO Kazuwa的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NAKAO Kazuwa', 18)}}的其他基金

Development and analysis of model rats for diseases of endocrinology and metabolism
内分泌代谢疾病模型大鼠的建立及分析
  • 批准号:
    23659476
  • 财政年份:
    2011
  • 资助金额:
    $ 39.81万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Physiological Function of Hormones Derived from Mesenchymal Cells and Its Failure
间充质细胞激素的生理功能及其失效
  • 批准号:
    21229013
  • 财政年份:
    2009
  • 资助金额:
    $ 39.81万
  • 项目类别:
    Grant-in-Aid for Scientific Research (S)
Translational research and development of novel diagnostic/therapeutic modalities for metabolic syndrome based on adipocyte endocrinology and adiposcience
基于脂肪细胞内分泌学和脂肪科学的代谢综合征新型诊断/治疗方式的转化研究和开发
  • 批准号:
    16109007
  • 财政年份:
    2004
  • 资助金额:
    $ 39.81万
  • 项目类别:
    Grant-in-Aid for Scientific Research (S)
Molecular Basis of Centrally-controled Energy Homeostasis -Focusing on Leptin Resistance-
中央控制能量稳态的分子基础 - 关注瘦素抵抗 -
  • 批准号:
    13307033
  • 财政年份:
    2001
  • 资助金额:
    $ 39.81万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Clinical implication of cardiovascular hormones
心血管激素的临床意义
  • 批准号:
    10307026
  • 财政年份:
    1998
  • 资助金额:
    $ 39.81万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A).
New Animal Models Of Leaness And Obesity by Genetic Engineering and its Application to Therapy
基因工程瘦和肥胖的新动物模型及其在治疗中的应用
  • 批准号:
    09557080
  • 财政年份:
    1997
  • 资助金额:
    $ 39.81万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Molecular and Clinical Study of Cardiovascular Hormones
心血管激素的分子和临床研究
  • 批准号:
    08044272
  • 财政年份:
    1996
  • 资助金额:
    $ 39.81万
  • 项目类别:
    Grant-in-Aid for international Scientific Research
Development of novel mouse models deficient in vasoactive substances-Clinical implication of the natriuretic peptide family and its application to gene therapy-
血管活性物质缺乏的新型小鼠模型的开发-利尿钠肽家族的临床意义及其在基因治疗中的应用-
  • 批准号:
    07557072
  • 财政年份:
    1995
  • 资助金额:
    $ 39.81万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Molecular Biology of Vasoactive Substances
血管活性物质的分子生物学
  • 批准号:
    06404037
  • 财政年份:
    1994
  • 资助金额:
    $ 39.81万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Molecular biology of vasoactive substances
血管活性物质的分子生物学
  • 批准号:
    06044129
  • 财政年份:
    1994
  • 资助金额:
    $ 39.81万
  • 项目类别:
    Grant-in-Aid for international Scientific Research

相似国自然基金

肾上腺髓质素调节血管钙化的细胞信号转导机制
  • 批准号:
    30470693
  • 批准年份:
    2004
  • 资助金额:
    20.0 万元
  • 项目类别:
    面上项目

相似海外基金

RAMP-altered class B GPCR hormone binding and signaling
RAMP 改变的 B 类 GPCR 激素结合和信号转导
  • 批准号:
    10678686
  • 财政年份:
    2012
  • 资助金额:
    $ 39.81万
  • 项目类别:
RAMP-altered Class B GPCR Hormone Recognition
RAMP 改变的 B 类 GPCR 激素识别
  • 批准号:
    8731948
  • 财政年份:
    2012
  • 资助金额:
    $ 39.81万
  • 项目类别:
RAMP-altered Class B GPCR Hormone Recognition
RAMP 改变的 B 类 GPCR 激素识别
  • 批准号:
    8914642
  • 财政年份:
    2012
  • 资助金额:
    $ 39.81万
  • 项目类别:
RAMP-altered class B GPCR hormone recognition
RAMP 改变的 B 类 GPCR 激素识别
  • 批准号:
    9384071
  • 财政年份:
    2012
  • 资助金额:
    $ 39.81万
  • 项目类别:
RAMP-altered class B GPCR hormone binding and signaling
RAMP 改变的 B 类 GPCR 激素结合和信号转导
  • 批准号:
    10798839
  • 财政年份:
    2012
  • 资助金额:
    $ 39.81万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了